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Abstract
Objective—Because depression and anxiety are typically studied in isolation, our purpose was to 
examine the relative importance of these overlapping emotional factors in predicting incident 
cardiovascular disease (CVD).
Methods—We examined depression and anxiety screens, and their individual items, as predictors 
of incident hard CVD events, myocardial infarction, and stroke over eight years in a diverse 
sample of 2,041 older primary care patients initially free of CVD. At baseline, participants 
completed self-report depression and anxiety screens. Data regarding CVD events were obtained 
from an electronic medical record system and the Centers for Medicare and Medicaid Services 
analytic files.
Results—During follow-up, 683 (33%) experienced a CVD event. Cox proportional hazards 
models – adjusted for demographic and CVD risk factors – revealed that a positive anxiety screen, 
but not a positive depression screen, was associated with an increased risk of a hard CVD event in 
separate models (Years 0–3: Anxiety HR=1.54, p<.001; Years 3+: Anxiety HR=0.99, p=.93; 
Depression HR=1.10, p=.41), as well as when entered into the same model (Years 0–3: Anxiety 
HR=1.53, p<.001; Years 3+: Anxiety HR=0.99, p=.99; Depression HR=1.03, p=.82). Analyses 
examining individual items and secondary outcomes showed that the anxiety-CVD association 
was largely driven by the feeling anxious item and the myocardial infarction outcome.
Conclusions—Anxiety, especially feeling anxious, is a unique risk factor for CVD events in 
older adults, independent of conventional risk factors and depression. Anxiety deserves increased 
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attention as a potential factor relevant to CVD risk stratification and a potential target of CVD 
primary prevention efforts.
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Introduction
Prospective studies of the past 30 years indicate that both depression and anxiety predict the 
onset of atherosclerotic cardiovascular disease (CVD), including coronary artery disease and 
cerebrovascular disease. Specifically, meta-analyses have demonstrated that adults with 
depression have a 57% greater risk and adults with anxiety have a 26% greater risk of 
developing CVD than those without elevations in these factors (1, 2). Most of this evidence, 
however, derives from studies in which these emotional factors were examined in isolation – 
i.e., investigations testing whether depression alone or anxiety alone predicts incident CVD. 
This approach is problematic due to the substantial overlap that exists between these 
emotional factors (3). To illustrate, depressive and anxiety disorders are highly comorbid 
(55–60%) (4), and measures of depressive and anxiety symptoms are moderately to highly 
correlated (r = 0.45–0.75) (5). As a result of this overlap, studies examining one factor at a 
time cannot determine whether depression and anxiety are independent CVD risk factors or 
whether one factor is merely a marker for the other factor that itself is the true CVD risk 
factor.
While there is a smaller but growing literature examining depression and anxiety as 
simultaneous predictors of incident CVD, these studies have yielded mixed results, and none 
has assessed the predictive utility of individual symptoms. For instance, some of these 
findings indicate that depression predicts incident CVD independent of anxiety (6–8), 
whereas others suggest that anxiety predicts CVD independent of depression (9–12). Yet 
another study found that both depression and anxiety predict incident CVD independent of 
each other (13). Thus, much is left to be learned about the relative importance of these 
emotional factors and their individual symptoms in predicting the onset of CVD (14). Such 
knowledge would be of use in (a) identifying patients at greatest CVD risk and in need of 
early and aggressive primary prevention and (b) informing the development of interventions 
targeting emotional factors to reduce CVD risk. Accordingly, the aim of the present study 
was to simultaneously examine depression and anxiety screens, as well as their individual 
items, as predictors of incident hard CVD events, myocardial infarction (MI), and stroke 
over eight years in a sample of 2,041 older primary care patients initially free of CVD.
Methods
Participants
Participants were primary care patients who underwent initial screening at the Indiana sites 
for the Improving Mood-Promoting Access to Collaborative Treatment (IMPACT) study, a 
multisite randomized controlled trial of collaborative care for late-life depression (15). From 
July 1999 to August 2001, all 3,675 patients aged ≥ 60 years attending two large urban 
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primary care clinics in a safety net healthcare system in Indianapolis, IN, were approached 
for screening during routine visits. About 80% of these patients were economically 
disadvantaged as indicated by receiving federal or county health insurance assistance (16). 
Because 172 patients refused the screening and five screens were incomplete, 3,498 (95.2%) 
patients had complete screens. From this cohort, we excluded (a) 25 (0.7%) patients for 
whom we could not match their IMPACT trial data with data from other sources (e.g., 
Medicare/Medicaid claims) and (b) 229 (6.5%) patients who were randomized in the 
IMPACT trial. We excluded randomized patients because we have previously shown that 
patients randomized to the IMPACT collaborative care intervention for depression have a 
significantly lower risk of a hard CVD event than patients randomized to usual depression 
care (17).
Because our focus is cardiovascular risk and not prognosis, we then excluded 1,203 (34.4%) 
patients with clinical CVD at baseline. To identify these patients, we merged data from the 
Regenstrief Medical Record System (18), one of largest and longest operating electronic 
medical records (earliest data from 1978), with data from the Centers for Medicare and 
Medicaid Services analytic files (earliest data from 1999). Baseline CVD was defined as the 
occurrence of any of the following events or procedures in the electronic medical record or 
Medicare/Medicaid data before the IMPACT screening date: (a) ischemic heart disease 
diagnosis (ICD-9 codes 410–414, 429.2), (b) laboratory evidence of an acute MI (creatine 
kinase-myocardial band isoenzyme value >3.0 ng/ml or troponin value >0.3 μg/L), (c) 
percutaneous coronary intervention (ICD-9 codes 00.66, 36.03, 36.06, 36.07, 36.09; CPT 
codes 92980–92984, 92995, 92996), (d) coronary artery bypass graft (ICD-9 codes 36.10–
36.19; CPT codes 33510–33536), (e) cerebrovascular disease diagnosis (ICD-9 codes 430–
434, 436–438), or (f) thrombolytic therapy (CPT code 37195). We used a broad definition of 
baseline CVD to minimize the likelihood of patients with preexisting clinical CVD being 
included in our cohort. Our final sample consisted of 2,041 older primary care patients 
initially free of clinical CVD (see Table 1 for participant characteristics). This represents 
58.3% of the patients initially screened, although the vast majority of exclusions were for 
CVD at baseline. Because our follow-up utilized existing data sources and required no 
patient contact, there was not any attrition other than the 25 patients mentioned above for 
whom we could not match data across sources.
This follow-up study was approved by the IUPUI Institutional Review Board and the 
Centers for Medicare and Medicaid Services Privacy Board. The depression and anxiety 
screens were administered as part of routine care. A waiver of consent was obtained to link 
electronic medical record and Medicare/Medicaid data.
Measures and Procedures
Depression and Anxiety Screens—During routine primary care visits, patients were 
administered a modified version of Patient Questionnaire of the Primary Care Evaluation of 
Mental Disorders (PRIME-MD) (19). The Patient Questionnaire is a self-report symptom 
measure designed to be an initial screen for common psychiatric disorders in medical 
populations. Patients responded yes or no to the question: “During the past month, have you 
been bothered a lot by [symptom]?” Our modified version included both depression items 
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(“little interest or pleasure in doing things” and “feeling down, depressed, or hopeless”) and 
two of the three anxiety items (“nerves or feeling anxious or on edge” and “worrying about a 
lot of different things”) of the original measure. Consistent with the PRIME-MD 
instructions,(19) patients who endorsed either of the two depression or anxiety items were 
coded as screening positive for depression or anxiety, respectively. When using the complete 
PRIME-MD procedure, patients who screen positive for a disorder then undergo a structured 
interview to confirm the diagnosis. This interview was not completed in our study. Even so, 
the Patient Questionnaire depression screen has moderate sensitivity (69%) and higher 
specificity (82%) for depressive disorder diagnoses made by mental health professionals, 
and the anxiety screen has higher sensitivity (94%) and lower specificity (53%) for anxiety 
disorder diagnoses (19).
Incident Cardiovascular Disease Events—The primary outcome of a hard CVD event 
was defined as the occurrence of any of the following events in the Regenstrief Medical 
Record System or Medicare/Medicaid data between the IMPACT screening date and 
December 31, 2008: (a) fatal MI (ICD-10 codes I21-I22 the first-listed cause of death), (b) 
acute MI diagnosis (ICD-9 code 410), (c) laboratory evidence of acute MI (creatine kinase-
myocardial band isoenzyme value >3.0 ng/ml or troponin value >0.3 μg/L), (d) fatal stroke 
(ICD-10 codes I60-I64 the first-listed cause of death), or (e) hemorrhagic (ICD-9 codes 430–
432) or nonhemorrhagic (ICD-9 codes 433.01, 433.11, 433.21, 433.31, 433.91, 434.01, 
434.11, and 434.91) stroke diagnosis. Our secondary outcomes were components of the 
primary outcome, namely: fatal/nonfatal MI (categories a-c only) and fatal/nonfatal stroke 
(categories d and e only). Death dates were extracted from the Medicare data, and causes of 
death were obtained from death certificates provided by the Indiana State Department of 
Health included in the electronic medical record. Patients were followed for a maximum of 
9.5 years (median = 8.3 years).
Other Baseline Factors—Data regarding demographic characteristics (age, sex, and 
race) and the presence of physician-diagnosed hypertension and diabetes were extracted 
from the Regenstrief Medical Record System, as has been described elsewhere (16). For 
each patient, we exacted the most recent total cholesterol value that was within five years of 
the screening date from the electronic medical record; those with a value ≥ 240 mg/dL were 
coded as having hypercholesterolemia. Similarly, those with a positive marker for smoking 
in the medical record during the same 5-year period were coded as smokers. Body mass 
index (BMI; kg/m2) was computed from height and weight recorded in the medical record. 
For 12 (0.6%) patients, missing values for height and weight were imputed with sex-specific 
median values. The PRIME-MD Patient Questionnaire included items assessing general 
perceived health (“Overall, would you say your health is: excellent, very good, good, fair, or 
poor.”), tiredness (“feeling tired or having low energy”), and sleep difficulties (“trouble 
sleeping”).
Data Analysis
To examine the relative importance of depression and anxiety screens in predicting future 
CVD events, we ran individual and simultaneous-entry Cox proportional hazards models 
predicting the primary (hard CVD events) and secondary (nonfatal/fatal MI and nonfatal/
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fatal stroke) outcomes. Patients were censored at date of death or December 31, 2008. 
Covariates in individual models were demographic factors (age, sex, and race) and CVD risk 
factors (hypertension, hypercholesterolemia, diabetes, smoking, and BMI). In these models, 
depression screen and anxiety screen were entered into separate models as the predictor 
variable. In the simultaneous-entry models, depression screen and anxiety screen were 
forced into the same model along with the covariates of the individual models to determine 
which screens were unique predictors of CVD events. The depression screen x anxiety 
screen interaction was also tested in these models. For screens that were predictors of CVD 
events, we performed a parallel set of individual and simultaneous-entry Cox models to 
examine the predictive utility of the screener items. For screener items that predicted CVD 
events, Kaplan-Meier survival curves were constructed to illustrate the time to first CVD 
event for patients who endorsed the item versus those who did not.
Because tests of non-proportionality (depression/anxiety variable x log time interactions) 
were not significant, the proportional hazards assumption was not rejected for models 
examining depression variables as predictors of hard CVD events (p = .61), nonfatal/fatal MI 
(p = .61), or nonfatal/fatal stroke (p = .13). This assumption was also not rejected for models 
examining anxiety variables as predictors of nonfatal/fatal MI (ps ≥.060) or stroke (p = .27). 
However, this assumption was rejected for models examining anxiety variables as predictors 
of hard CVD events (anxiety screen: p = .012; feeling anxious: p = .044; worry: p = .028). In 
these instances, we also calculated separate hazard ratios for Years 0–3 and Years 3+ by 
including an anxiety variable x time period interaction in the models. These time periods 
were selected because examination of the hazard ratios for each year of follow-up revealed 
that there was a consistent decrease in effect sizes across models between Years 3 and 4.
Supplemental analyses were performed to explore key associations. First, to diminish the 
possibility of reverse causality (e.g., an impending CVD event leading a patient to report 
depressive or anxiety symptoms), we reran individual Cox models after excluding patients 
who experienced a MI during the first year of follow-up. Second, to decrease the probability 
that observed relationships were due to confounding by poor overall health or sleep 
disturbance, we ran individual Cox models further adjusting for the Patient Questionnaire 
general perceived health item or the feeling tired and trouble sleeping items. Third, to 
evaluate whether observed relationships were moderated by sex or race, we tested two- and 
three-way interactions involving predictor variables, sex, and race. Sensitivity analyses were 
also performed to explore the effect of including (rather than excluding) depressed patients 
randomized in the IMPACT trial on the pattern of results. Specifically, we reran the 
individual Cox models for hard CVD events shown in Table 1, which also included dummy 
variables adjusting for IMPACT treatment group assignment (randomized to IMPACT group 
vs. randomized to usual care group; not randomized versus randomized to usual care group). 
SAS 9.3 software was used to conduct all analyses.
Results
Depression and Anxiety Screens
In our cohort of 2,041 primary care patients, 270 (13.2%) patients screened positive for 
depression (3.0% little interest item only, 4.6% feeling depressed item only, 5.6% both 
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items), and 849 (41.6%) screened positive for anxiety (10.5% feeling anxious item only, 
14.9% worry item only, 16.2% both items). The positive anxiety screen rate (48.6%) 
reported for the Patient Questionnaire in the PRIME-MD validation study is similar to our 
rate; however, the positive depression screen rate (32.5%) reported in that study is higher 
than ours (19). We may have observed a lower rate of positive depression screens than in the 
validation study due to our older sample (20) and exclusion of patients with clinical CVD 
(21).
As was expected, depression and anxiety often co-occurred, with 209 (10.2%) patients 
screening positive for both. This comorbidity rate is similar to that reported in prior studies 
of primary care patients using brief screeners (22). Despite this comorbidity, correlations 
between the depression and anxiety variables were small to moderate (phi coefficients 
ranged from 0.21 to 0.31), indicating that multicollinearity is not an issue with our 
simultaneous-entry models.
Incident Cardiovascular Disease Events
During the 8-year follow-up period, 683 (33.5%) patients experienced the primary outcome 
of a hard CVD event, consisting of 487 nonfatal MIs, 172 nonfatal strokes, 10 concurrent 
nonfatal MIs and strokes, 11 fatal MIs, and 3 fatal strokes as first events. The median time to 
hard CVD event for those with an event was 3.9 years (IQR: 1.8–6.1 years). A total of 553 
(27.1%) patients and 235 (11.5%) patients experienced the secondary outcome of fatal/
nonfatal MI and fatal/nonfatal stroke, respectively. CVD event rates were high, which was 
not surprising given the demographic characteristics (i.e., older age, high percent African 
American, and lower socioeconomic status) and high CVD risk factor burden in our cohort 
(see Table 1).
Depression and Anxiety Screens as Predictors of Incident Cardiovascular Disease Events
Event rates for patients with positive versus negative depression screens were 35.2% versus 
33.2% for hard CVD events, 28.5% versus 26.9% for MI, and 13.3% versus 11.2% for 
stroke. For patients with positive versus negative anxiety screens, event rates were 34.9% 
versus 32.5% for hard CVD events, 28.9% versus 25.8% for MI, and 12.1% versus 11.1% 
for stroke.
As is shown in Table 2, individual Cox proportional hazards models adjusted for 
demographic and CVD risk factors revealed that a positive anxiety screen (Years 0–3: p < .
001; Years 3+: p = .93), but not a positive depression screen (p = .41), predicted hard CVD 
events. Specifically, a positive anxiety screen was associated with a 54% greater risk of a 
CVD event for Years 0–3; however, there was no such association for Years 3+. Of note, we 
calculated separate hazard ratios for Years 0–3 and Years 3+ because the proportional 
hazards assumption was rejected for models examining anxiety variables as predictors of 
hard CVD events (see Data Analysis). The simultaneous-entry Cox models yielded the same 
pattern of results (see Table 2). A positive anxiety screen (p < .001) was associated with an 
53% greater risk of a CVD event for Years 0–3 after adjustment for depression screen, while 
anxiety screen for Years 3+ (p = .99) and depression screen (p = .82) remained unrelated to 
Stewart et al. Page 6
Psychosom Med. Author manuscript; available in PMC 2017 June 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
CVD events. The depression screen x anxiety screen interaction was not significant for 
Years 0–3 or Years 3+ (ps = .67 and .82).
We observed similar results for fatal/nonfatal MI (see Table 2). A positive anxiety screen 
was associated with a 22% greater risk of a MI during the 8-year follow-up period in both 
individual and simultaneous-entry Cox models (ps = .023 and .028), whereas depression 
screen was not a predictor in either model (ps = .57 and .95). In contrast, neither depression 
screen (ps = .32 and .51) nor anxiety screen (ps = .18 and .27) predicted fatal/nonfatal stroke 
in the individual and simultaneous-entry Cox models (see Table 2). However, three of the 
four hazard ratios for stroke were comparable in magnitude to those that were significant for 
other outcomes, suggesting that lower statistical power due to the smaller number of stroke 
events may be responsible for these null results. The depression screen x anxiety screen 
interaction was not significant for fatal/nonfatal MI or stroke (ps = .52 and .92).
Because anxiety screen was associated with hard CVD events and fatal/nonfatal MI, we 
examined the utility of the two anxiety items in predicting these outcomes. As can be seen in 
Table 2, individual Cox models revealed that the feeling anxious item (p < .001) and the 
worry item (p = .010) were predictors of hard CVD events for Years 0–3. After adjustment 
for depression screen in the simultaneous-entry Cox models, the feeling anxious item (p = .
001) and the worry item (p = .015) remained predictive of hard CVD events. However, when 
both the feeling anxious item (HR = 1.42, 95% CI: 1.08–1.87, p = .014) and worry item (HR 
= 1.21, 95% CI: 0.92–1.60, p = .17) were forced into the same simultaneous-entry model, 
only the feeling anxious item continued to predict. Neither item predicted hard CVD events 
for Years 3+ across models. For fatal/nonfatal MI, the feeling anxious item (ps = .004 and .
005), but not the worry item (ps = .47 and .56), was a predictor in both individual and 
simultaneous-entry Cox models. Figure 1 displays Kaplan-Meier survival curves illustrating 
the time to hard CVD events (left panel) and fatal/nonfatal MI (right panel) for patients who 
endorsed the feeling anxious item (positive) versus those who did not (negative). Given that 
depression screen did not predict any outcome, analyses examining the depression items 
were not performed.
Supplemental and Sensitivity Analyses
Because the primary analyses indicated that the observed associations were largely driven by 
the link between the feeling anxious item and fatal/nonfatal MI, supplemental analyses 
examined this relationship only. In the individual Cox model from which we excluded 
patients who experienced a MI during the first year of follow-up (n = 76), the feeling 
anxious item remained a predictor of MI (HR = 1.30, 95% CI: 1.07–1.58, p = .009). 
Similarly, individual Cox models further adjusted for the PRIME-MD general perceived 
health item or the two items indicative of sleep disturbance revealed that the feeling anxious 
item continued to predict MI (perceived health-adjusted: HR = 1.25, 95% CI: 1.04–1.51, p 
= .021; feeling tired- and trouble sleeping-adjusted: HR = 1.25, 95% CI: 1.03–1.51, p = .
025). Finally, individual Cox models testing interactions revealed that feeling anxious item x 
sex (p = .73), x race (p = .93), and x sex x race interactions (p = .42) were all not significant, 
indicating that sex and race were not moderators. To illustrate, the feeling anxious-MI 
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hazard ratio was 1.33 for African American women, 1.34 for African American men, 1.22 
for Caucasian women, and 1.45 for Caucasian men.
In the cohort for the sensitivity analyses that included depressed patients randomized in the 
IMPACT trial (N = 2,162; 724 hard CVD events), the rate of positive depression (16.7%) 
and anxiety (43.9%) screens both increased slightly. Individual Cox models revealed that 
including these patients did not alter the pattern of results. Anxiety screen (Years 0–3: HR = 
1.54, 95% CI: 1.22–1.94, p < .001; Years 3+: HR = 1.00, 95% CI: 0.82–1.21, p = .99), the 
feeling anxious item (Years 0–3: HR = 1.52, 95% CI: 1.20–1.93, p < .001; Years 3+: HR = 
1.08, 95% CI: 0.88–1.34, p = .47), and the worry item (Years 0–3: HR = 1.38, 95% CI: 
1.09–1.75, p = .008; Years 3+: HR = 0.94, 95% CI: 0.76–1.15, p = .53) – but not depression 
screen (HR = 1.10, 95% CI: 0.90–1.33, p = .33) – predicted hard CVD events.
Discussion
Our aim was to simultaneously examine depression and anxiety screens and their individual 
items as predictors of CVD events. We found that a positive screen for anxiety, but not for 
depression, predicted incident hard CVD events in a large, diverse sample of older primary 
care patients initially free of CVD. Specifically, patients who screened positive for anxiety 
had a 53% greater risk of a MI or stroke during Years 0–3 (but not Years 3+) than those who 
screened negative – after adjustment for demographic factors, conventional risk factors, and 
depression status. Analyses examining the individual items and secondary outcomes 
revealed that the association between a positive anxiety screen and CVD events was largely 
driven by the feeling anxious item and the incident MI outcome. Supplemental results 
indicated that the feeling anxious-incident MI relationship did not reflect an impending 
CVD event leading to anxiety, was not due to confounding by poor overall health or sleep 
disturbance, and did not vary across sex and racial groups. In total, our results suggest that 
anxiety, in particular feeling anxious, is a risk factor for CVD in older adults, independent of 
conventional risk factors and depression. Although our findings conflict with studies 
reporting that depression predicts incident CVD independent of anxiety (6–8), they are in 
line with studies reporting that anxiety predicts independent of depression (9–12).
Why was anxiety screen, but not depression screen, a predictor of hard CVD events in our 
study? One possibility is that anxiety may be a stronger trigger of acute coronary syndromes 
than depression, perhaps because a positive anxiety screen could indicate the presence of 
anxiety episodes, such as panic attacks. Along with anger outbursts, anxiety episodes have 
been identified as psychosocial triggers of acute coronary syndromes in vulnerable adults 
(23). In the Onset Study, episodes of high anxiety were associated with a 60% increase in 
the risk of MI in the subsequent two hours (24). Conflicting with this possibility, however, is 
evidence that episodes of depressed mood may also trigger acute coronary syndromes (25). 
Psychosocial triggers are thought to promote acute coronary syndromes by bringing about 
pathophysiologic increases in blood pressure, heart rate, vasoconstriction, and coagulation 
(26). A second possibility is that our depression measure did not capture the most 
cardiotoxic aspects of this multidimensional construct. Some evidence suggests that the 
somatic cluster of depressive symptoms (e.g., fatigue, sleep disturbance, and appetite 
changes) is a stronger predictor of CVD-related outcomes than the cognitive-affective cluster 
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(e.g., depressed mood and trouble concentrating) (27–29). The PRIME-MD, however, 
assessed only the affective symptoms of depressed mood and anhedonia. Thus, it is 
unknown whether depression would have also predicted CVD events had a broader 
assessment been completed. A third possibility is that our depression screen, due to its 
moderate sensitivity, did not identify patients with subthreshold symptoms as depression 
cases. This could have weakened depression effects, given that both depressive disorders and 
subthreshold elevations in depressive symptoms predict incident CVD (2). Conversely, our 
anxiety screen likely identified patients with subthreshold symptoms as anxiety cases on 
account of its higher sensitivity, which could have strengthened anxiety effects. A final 
possibility is that the patients with the most severe depressive symptoms were randomized in 
the IMPACT trial and, thus, excluded from our primary cohort. This likely restricted the 
range of depression severity in our cohort, which could have weakened depression effects. 
Although sensitivity analyses including the randomized patients did not change the pattern 
of results, half of these patients received the IMPACT intervention. This could have also 
weakened depression effects, as we have previously shown that this intervention is 
associated with a lower risk of hard CVD events (17). In addition to being potential 
explanations for our findings, some of these possibilities could also explain the inconsistent 
pattern of results across past studies examining depression and anxiety as simultaneous 
predictors of CVD outcomes.
A related question is: Why did the feeling anxious item, but not worry item, predict CVD 
events in our study? We offer three potential explanations, although future research is 
needed to examine these possibilities. One, the feeling anxious item (“nerves or feeling 
anxious or on edge”), versus the worry item (“worrying about a lot of different things”), may 
have been a stronger marker of the presence of the anxiety episodes discussed above, which 
in turn could trigger acute coronary syndromes. Two, similar to depression, recent findings 
suggest that the somatic symptoms of anxiety (e.g., palpitation, sweating, and trembling) 
may be more predictive of CVD events than the cognitive-affective symptoms (e.g., worry 
and anxious mood) (11). It is plausible that the feeling anxious item primarily captures the 
somatic symptoms of anxiety, whereas the worry item largely reflects the cognitive-affective 
symptoms. Three, the feeling anxious item could be marker of pre-existing autonomic 
dysregulation or poor overall health. However, we reduced the likelihood of such reverse 
causality by excluding patients who experienced a MI during the first year and by adjusting 
for general perceived health and sleep disturbance in the supplemental analyses.
Our study has limitations that should be noted. First, we used brief screeners to detect 
depression and anxiety cases, rather than a structured clinical interview. This certainly led to 
some misclassification – i.e., patients with subthreshold symptom elevations being classified 
as cases, particularly when it comes to anxiety. The anxiety screen of PRIME-MD Patient 
Questionnaire has been found to have higher sensitivity (94%) and lower specificity (53%) 
(19). This higher sensitivity and lower specificity, however, may not be problematic here 
and, in fact, may have increased the predictive utility of the anxiety screen, given that 
subthreshold elevations in anxiety symptoms have been found to predict incident CVD (14). 
Nonetheless, future studies utilizing clinical interview-based measures are needed to 
simultaneously examine depressive and anxiety disorders as predictors of incident CVD 
events. Second, due to the lower number of events, our analyses predicting incident stroke 
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appear to be underpowered. We failed to detect effects that are potentially clinically 
meaningful and that were similar in magnitude to effects that were significant for the other 
CVD outcomes. Thus, conclusions involving the stroke outcome should be drawn with 
caution. Third, our last date of follow-up was in 2008. However, it is doubtful that this 
influenced our results. Although the CVD death rate has been on the decline (30), this trend 
is thought to be attributable to improvements in traditional risk factor management and 
secondary prevention, not the detection and treatment of psychological factors like 
depression and anxiety. Finally, because our sample consisted of older primary care patients, 
most of whom were economically disadvantaged, future studies are needed to determine 
whether our results generalize to younger adults and those of higher socioeconomic status.
In addition to the limitations, it is worth noting our study’s unique methodological strengths. 
One, our sample of primary care patients with high CVD risk factor burden enhances the 
clinical relevance of our findings, as CVD risk stratification and primary prevention often 
occur in this patient population and clinical setting (31). Two, our sample includes high 
percentages of traditionally underrepresented groups – namely, African Americans and the 
medically uninsured/underinsured. Three, we identified a high number of incident CVD 
events using multiple data sources, reducing the likelihood of outcome misclassification and 
allowing us to predict incident MI and stroke together and separately. Four, our 
comprehensive analytic approach (i.e., individual, simultaneous-entry, and item-level 
analyses) provide refined views of the depression-CVD and anxiety-CVD relationships.
In summary, we found that anxiety, especially feeling anxious, is a unique risk factor for 
hard CVD events in older adults with high CVD risk factor burden, independent of 
conventional risk factors and depression. Our findings, combined with those of similar 
studies, indicate that anxiety deserves increased attention as a potential factor relevant to 
CVD risk stratification and a potential target of CVD primary prevention efforts. For 
instance, primary care patients with anxiety may be a subpopulation at heightened risk for 
CVD events for whom earlier and more aggressive primary prevention is warranted. In 
addition, there is a current need for treatment studies to evaluate whether efficacious anxiety 
interventions, delivered before the onset of clinical CVD, can decrease CVD risk markers or 
prevent incident CVD events.
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CVD cardiovascular disease
MI myocardial infarction
IMPACT Improving Mood-Promoting Access to Collaborative 
Treatment
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ICD-9 International Classification of Diseases, 9th Revision
ICD-10 International Classification of Diseases, 10th Revision
CPT current procedural terminology
PRIME-MD Primary Care Evaluation of Mental Disorders
BMI body mass index
HR hazard ratio
CI confidence interval
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Figure 1. 
Kaplan-Meier survival curves illustrating the time to (A) hard CVD events and (B) fatal or 
nonfatal MI over the 8-year follow-up period for primary care patients who endorsed the 
feeling anxious items (positive) versus those who did not (negative). CVD = cardiovascular 
disease. MI = myocardial infarction.
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Table 1
Baseline Characteristics of Participants (N = 2,041)
Demographic Factors
Age (years), mean (SD) 68.5 (6.9)
Female, n (%) 1,482 (72.6)
African American, n (%) 1,175 (57.6)
Cardiovascular Risk Factors
Hypertension, n (%) 1,458 (71.4)
Hypercholesterolemia (total cholesterol ≥ 240 mg/dL), n (%) 349 (17.1)
Diabetes, n (%) 571 (28.0)
Smoker, n (%) 730 (35.8)
Body-Mass Index (kg/m2), mean (SD) 30.3 (8.0)
Depression and Anxiety Screens
Positive PRIME-MD Depression Screen, n (%) 270 (13.2)
Positive PRIME-MD Anxiety Screen, n (%) 849 (41.6)
Note. PRIME-MD = Primary Care Evaluation of Mental Disorders.
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Table 2
Cox Proportional Hazards Models Predicting Incident Cardiovascular Disease (CVD) Events
Individual Modelsa
HR (95% CI)
Simultaneous-Entry Modelsb
HR (95% CI)
Hard CVD Events (683, 33%)
Depression Screen 1.10 (0.88–1.36) 1.03 (0.82–1.29)
 Little Interest Item --- ---
 Depressed Mood Item --- ---
Anxiety Screenc
  Years 0–3 1.54* (1.21–1.96) 1.53* (1.20–1.95)
  Years 3+ 0.99 (0.81–1.21) 0.99 (0.80–1.21)
 Feeling Anxious Itemc
  Years 0–3 1.53* (1.19–1.97) 1.53* (1.19–1.98)
  Years 3+ 1.09 (0.87–1.36) 1.09 (0.86–1.36)
 Worry Itemc
  Years 0–3 1.39* (1.08–1.78) 1.37* (1.06–1.77)
  Years 3+ 0.94 (0.75–1.17) 0.93 (0.74–1.16)
Fatal or Nonfatal MI (553, 27%)
Depression Screen 1.07 (0.84–1.37) 0.99 (0.77–1.28)
 Little Interest Item --- ---
 Depressed Mood Item --- ---
Anxiety Screen 1.22* (1.03–1.45) 1.22* (1.02–1.46)
 Feeling Anxious Item 1.31* (1.09–1.57) 1.32* (1.09–1.60)
 Worry Item 1.07 (0.89–1.29) 1.06 (0.87–1.28)
Fatal or Nonfatal Stroke (235, 12%)
Depression Screen 1.20 (0.84–1.71) 1.13 (0.78–1.64)
 Little Interest Item --- ---
 Depressed Mood Item --- ---
Anxiety Screen 1.20 (0.92–1.56) 1.17 (0.89–1.54)
 Feeling Anxious Item --- ---
 Worry Item --- ---
Note. N = 2,041. HR = hazard ratio. CI = confidence interval. MI = myocardial infarction.
aAdjusted for age, sex, race, hypertension, hypercholesterolemia, diabetes, smoking, and body-mass index. Age (HR = 1.04, 95% CI: 1.03–1.06, p 
< .001), being male (HR = 1.28, 95% CI: 1.08–1.51, p = .004), diabetes (HR = 1.55, 95% CI: 1.32–1.82, p < .001), and being a smoker (HR = 1.33, 
95% CI: 1.13–1.56, p = .001) at baseline were independent predictors of hard CVD events in the expected directions.
bAdjusted for age, sex, race, hypertension, hypercholesterolemia, diabetes, smoking, body-mass index, and depression or anxiety screen.
c
Because the proportional hazards assumption was rejected, results of piecewise models are presented for the time periods Years 0–3 and Years 3+.
*p < .05
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